TW296983B - - Google Patents
Download PDFInfo
- Publication number
- TW296983B TW296983B TW083109726A TW83109726A TW296983B TW 296983 B TW296983 B TW 296983B TW 083109726 A TW083109726 A TW 083109726A TW 83109726 A TW83109726 A TW 83109726A TW 296983 B TW296983 B TW 296983B
- Authority
- TW
- Taiwan
- Prior art keywords
- nephritis
- quinolone
- propionic acid
- active ingredient
- pharmaceutically acceptable
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP26341793 | 1993-10-21 | ||
| JP26341993 | 1993-10-21 | ||
| JP26341893 | 1993-10-21 | ||
| JP8964194 | 1994-04-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW296983B true TW296983B (ja) | 1997-02-01 |
Family
ID=27467652
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW083109726A TW296983B (ja) | 1993-10-21 | 1994-10-20 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US5637597A (ja) |
| EP (1) | EP0674515B1 (ja) |
| JP (1) | JP2839847B2 (ja) |
| KR (1) | KR100191191B1 (ja) |
| CN (1) | CN1073418C (ja) |
| AT (1) | ATE184793T1 (ja) |
| AU (1) | AU683697B2 (ja) |
| CA (1) | CA2150546C (ja) |
| DE (1) | DE69420832T2 (ja) |
| DK (1) | DK0674515T3 (ja) |
| ES (1) | ES2138092T3 (ja) |
| GR (1) | GR3032091T3 (ja) |
| TW (1) | TW296983B (ja) |
| WO (1) | WO1995011026A1 (ja) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR004214A1 (es) * | 1995-10-12 | 1998-11-04 | Otsuka Pharma Co Ltd | Una preparación de gotas oftálmicas para la cura de enfermedades oftálmicas |
| DE10029404B4 (de) * | 2000-06-15 | 2009-10-29 | Jagotec Ag | Arzneiformulierung enthaltend Ciclosporin und deren Verwendung |
| FR2812548B1 (fr) * | 2000-08-01 | 2002-09-20 | Sanofi Synthelabo | Utilisation de derives de quinolein-2(1h)-one ou un de leurs sels pharmaceutiquement acceptable pour la preparation d'un medicament destine au traitement de l'insuffisance renale |
| US7408078B2 (en) * | 2002-10-08 | 2008-08-05 | Wyeth | Anthranilic acid derivatives useful in treating infection with hepatitis C virus |
| ATE373502T1 (de) * | 2003-07-30 | 2007-10-15 | Otsuka Pharma Co Ltd | Carbostyril-derivative zur beschleunigten speichelabsonderung |
| TWI340650B (en) * | 2004-01-21 | 2011-04-21 | Otsuka Pharma Co Ltd | Amine saly of carbostyril derivative |
| MY149159A (en) | 2005-11-15 | 2013-07-31 | Hoffmann La Roche | Method for treating joint damage |
| MY157582A (en) * | 2007-08-10 | 2016-06-30 | Otsuka Pharma Co Ltd | Medical composition containing rebamipipe |
| KR101104634B1 (ko) * | 2009-08-25 | 2012-01-12 | 한림제약(주) | 레바미피드를 포함하는 류마티스 관절염 예방 또는 치료용 약학 조성물 |
| KR101182114B1 (ko) * | 2010-03-05 | 2012-09-12 | 한림제약(주) | 유효성분으로서 레바미피드를 함유하는 골관절염 예방 또는 치료용 약학 조성물 |
| WO2012114317A1 (en) | 2011-02-25 | 2012-08-30 | Nuformix Limited | Novel rebamipide complexes and cocrystals |
| AR085527A1 (es) | 2011-03-24 | 2013-10-09 | Otsuka Pharma Co Ltd | Una composicon farmaceutica para tratar una enfermedad en la cavidad oral que comprende rebamipida |
| JP6294773B2 (ja) * | 2014-06-27 | 2018-03-14 | 株式会社ナールスコーポレーション | 口腔粘膜疾患の予防または治療用経口製剤 |
| WO2022128054A1 (en) | 2020-12-14 | 2022-06-23 | Symrise Ag | Medicament for fighting inflammatory conditions of human skin (iv) |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4578381A (en) * | 1982-07-05 | 1986-03-25 | Otsuka Pharmaceutical Co., Ltd. | Carbostyril derivatives |
| GB8334494D0 (en) * | 1983-12-24 | 1984-02-01 | Tanabe Seiyaku Co | Carbostyril derivatives |
| JPS63119467A (ja) * | 1987-10-21 | 1988-05-24 | Otsuka Pharmaceut Co Ltd | カルボスチリル誘導体 |
| JPH02178227A (ja) * | 1988-12-28 | 1990-07-11 | Otsuka Pharmaceut Co Ltd | 腎炎治療剤 |
| JP2812998B2 (ja) * | 1989-08-14 | 1998-10-22 | 大塚製薬 株式会社 | 胃炎治療剤 |
| DK0543018T3 (da) * | 1991-06-07 | 1996-02-05 | Otsuka Pharma Co Ltd | Antidiabetikum |
| DK0552373T3 (da) * | 1991-07-03 | 1999-12-27 | Otsuka Pharma Co Ltd | Apoptoseregulator |
| TW227558B (ja) * | 1992-05-14 | 1994-08-01 | Otsuka Pharma Co Ltd | |
| JP2872546B2 (ja) * | 1992-11-26 | 1999-03-17 | 大塚製薬株式会社 | 腸粘膜障害保護剤 |
| AU5715994A (en) * | 1992-12-24 | 1994-07-19 | Otsuka Pharmaceutical Co., Ltd. | Psoriasis remedy |
| CA2134880A1 (en) * | 1993-03-02 | 1994-09-03 | Akira Matsumori | Graft rejection inhibitor and il-1 production inhibitor |
-
1994
- 1994-10-17 JP JP6250473A patent/JP2839847B2/ja not_active Expired - Fee Related
- 1994-10-17 CA CA002150546A patent/CA2150546C/en not_active Expired - Lifetime
- 1994-10-17 DK DK94929670T patent/DK0674515T3/da active
- 1994-10-17 AT AT94929670T patent/ATE184793T1/de active
- 1994-10-17 US US08/448,577 patent/US5637597A/en not_active Expired - Lifetime
- 1994-10-17 WO PCT/JP1994/001739 patent/WO1995011026A1/en active IP Right Grant
- 1994-10-17 AU AU78641/94A patent/AU683697B2/en not_active Expired
- 1994-10-17 DE DE69420832T patent/DE69420832T2/de not_active Expired - Lifetime
- 1994-10-17 KR KR1019950702533A patent/KR100191191B1/ko not_active IP Right Cessation
- 1994-10-17 EP EP94929670A patent/EP0674515B1/en not_active Expired - Lifetime
- 1994-10-17 CN CN94190812.7A patent/CN1073418C/zh not_active Expired - Lifetime
- 1994-10-17 ES ES94929670T patent/ES2138092T3/es not_active Expired - Lifetime
- 1994-10-20 TW TW083109726A patent/TW296983B/zh not_active IP Right Cessation
-
1999
- 1999-12-08 GR GR990403182T patent/GR3032091T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR100191191B1 (ko) | 1999-06-15 |
| DE69420832T2 (de) | 2000-01-13 |
| EP0674515A1 (en) | 1995-10-04 |
| WO1995011026A1 (en) | 1995-04-27 |
| ATE184793T1 (de) | 1999-10-15 |
| DK0674515T3 (da) | 1999-12-20 |
| GR3032091T3 (en) | 2000-03-31 |
| EP0674515B1 (en) | 1999-09-22 |
| CN1117268A (zh) | 1996-02-21 |
| JPH0812578A (ja) | 1996-01-16 |
| CN1073418C (zh) | 2001-10-24 |
| JP2839847B2 (ja) | 1998-12-16 |
| ES2138092T3 (es) | 2000-01-01 |
| US5637597A (en) | 1997-06-10 |
| CA2150546C (en) | 2004-11-09 |
| CA2150546A1 (en) | 1995-04-27 |
| AU7864194A (en) | 1995-05-08 |
| DE69420832D1 (de) | 1999-10-28 |
| KR950703957A (ko) | 1995-11-17 |
| AU683697B2 (en) | 1997-11-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW296983B (ja) | ||
| Sternberg et al. | Effect of serotonin (5-HT) and other monoamines on murine macrophages: modulation of interferon-gamma induced phagocytosis. | |
| DE69006628T2 (de) | Pharmazeutische Zusammensetzung, enthaltend Loratadin, Ibuprofen und Pseudoephedrin. | |
| DE69835441T2 (de) | Behandlung von t-helfer zell typ 2 vermittelten immunkrankheiten mit retinoid antagonisten | |
| AU667864B2 (en) | Pharmaceutical compositions | |
| AU780797B2 (en) | Use of xanthophylls, astaxanthin e.g., for treatment of autoimmune diseases, chronic viral and intracellular bacterial infections | |
| Crow et al. | The coincidence of schizophrenia and Parkinsonism: some neurochemical implications | |
| JP3010007B2 (ja) | 配合下剤 | |
| Schwietz et al. | Allergic fungal sinusitis | |
| JP2000510859A (ja) | 神経変性疾患の治療に有用な医薬組成物の調製のためのｐ―アミノフェノール誘導体類の利用 | |
| JPH04505758A (ja) | 即効で増強された解熱応答 | |
| Rosenblatt et al. | Successful treatment of chronic mucocutaneous candidiasis with ketoconazole | |
| DE19850445A1 (de) | Arzneimittel zur topischen Behandlung entzündlicher Darmerkrankungen | |
| CA2310926C (en) | A use of galantamine for the treatment of neuropsychiatric behaviour associated with alzheimer's disease | |
| JPS59210021A (ja) | リポキシゲナ−ゼ代謝産物に起因する疾患の予防治療剤 | |
| JPH08109128A (ja) | アレルギー性皮膚疾患治療用外用剤 | |
| JPH03287530A (ja) | 免疫抑制剤 | |
| DE69516602T2 (de) | Verwendung von Bifemelan zur Herstellung eines Arzneimittels zur Behandlung der Hyperkinesie | |
| EP0669826A1 (de) | (-)-metrifonat enthaltendes arzneimittel | |
| AU2002236141A1 (en) | Method of treatment | |
| CN101291667A (zh) | 调节表皮细胞间黏附力的含金属药用组合物 | |
| DE3686538T2 (de) | Verwendung von dibenz(cd,f)indol-derivaten zur praevention vom alkoholmissbrauch. | |
| CA2202425A1 (en) | A novel anti-spasmodic and antiinflammatory composition and a process for the manufacture thereof | |
| WO2020190703A1 (en) | Methods for wound treatment | |
| AU645690B2 (en) | Antidiabetic |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Annulment or lapse of patent due to non-payment of fees |